Meso Compounds have been defined by themselves, as well as by their relationship with another group of diastereomeric combinations, C2 symmetrical ones, isomer to meso. Every meso compound should present a homodimer equivalent able to display at least one C2 symmetrical isomer. Cahn-Ingold-Prelog test, however limited, is also valuable. A systematization of meso combinations includes the following types: (A) meso Homodimers possessing one super-symmetric isomer or two real or envisaged C2 symmetrical enantiomers; (B) meso Heterodimers with a binding support having geometric or optical symmetry (e.g. >CR2, etc.). (C) meso Heterodimers with a binding support devoid of symmetry (of the form >CRR’, etc.), seeable as meso, and provable in this way not by themselves but by their equivalent meso homodimers. A paradoxical behavior has been shown at one of inositol isomers, in comparison with the others. Moreover, a new group of compounds has been disclosed, which are concomitantly meso and C2 symmetrical, and of this reason they have been called super- symmetrical.
No takes yet. Share an insight, caveat, or question.
Dumitru Petru Iga (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: